Table 4. Overall clinical response to betahistine treatment assessed by physicians and patients.
Overall clinical response | Assessed by physicians, n (%) | Assessed by patients, n (%) | ||
---|---|---|---|---|
Visit 2 | End of treatment | Visit 2 | End of treatment | |
Poor | 3 (1.0) | 2 (0.7) | 3 (1.0) | 4 (1.3) |
Fair | 71 (23.4) | 15 (4.9) | 69 (22.7) | 10 (3.3) |
Good | 185 (60.9) | 162 (53.1) | 190 (62.5) | 162 (53.1) |
Excellent | 45 (14.8) | 126 (41.3) | 42 (13.8) | 129 (42.3) |
Totala | 304b | 305 | 304b | 305 |
a For 60-day treatment group;
b N = 304 due to one patient having a combined Visit 2 and 3, which was only inputted as Visit 3